ChemFeeds Site Navigation:
Journal Selection:
Search:

99) Block CSF-1R to Improve Checkpoint Blockade in Neuroblastoma (Clinical Cancer Research) Sunday July 31st 2016


100) MIR21, PTGS2, and Colorectal Cancer (Clinical Cancer Research) Sunday July 31st 2016


101) ALK Fusion in Colorectal Carcinoma (Clinical Cancer Research) Sunday July 31st 2016


102) PET Imaging of Pancreatic Cancer (Clinical Cancer Research) Sunday July 31st 2016


103) Multidimensional ClinOmics for Precision Therapy (Clinical Cancer Research) Sunday July 31st 2016


104) Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL (Clinical Cancer Research) Sunday July 31st 2016


105) Intrapleural Ad.IFN to Treat Mesothelioma (Clinical Cancer Research) Sunday July 31st 2016


106) Phase III Trial of CIMAvax-EGF in Advanced NSCLC Patients (Clinical Cancer Research) Sunday July 31st 2016


107) Enzalutamide and Docetaxel in mCRPC (Clinical Cancer Research) Sunday July 31st 2016


108) HRD Predicts Response to Platinum Therapy in TNBC (Clinical Cancer Research) Sunday July 31st 2016


109) Relationship between Tumor Biomarkers and Efficacy with TDM1 (Clinical Cancer Research) Sunday July 31st 2016


110) Ruxolitinib for the Treatment of CMML (Clinical Cancer Research) Sunday July 31st 2016


111) TIL Therapy for Melanoma Patients with Attenuated IL2 Dose (Clinical Cancer Research) Sunday July 31st 2016


112) Cancer Tills the Premetastatic Field (Clinical Cancer Research) Sunday July 31st 2016


113) Endothelial Cell FAK in Cancer Treatment (Clinical Cancer Research) Sunday July 31st 2016


114) Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer (Clinical Cancer Research) Sunday July 31st 2016


115) Predictive Gene Signatures for HNSCC Cetuximab Chemotherapy (Clinical Cancer Research) Sunday July 31st 2016


116) Ruxolitinib in Chronic Myelomonocytic Leukemia (Clinical Cancer Research) Sunday July 31st 2016


117) Correction: Molecular Pathways: IDH2 Mutations--Co-opting Cellular Metabolism for Malignant Transformation (Clinical Cancer Research) Thursday July 14th 2016


118) Correction: Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening (Clinical Cancer Research) Thursday July 14th 2016


119) Correction: The Notch Target Hes1 Directly Modulates Gli1 Expression and Hedgehog Signaling: A Potential Mechanism of Therapeutic Resistance (Clinical Cancer Research) Thursday July 14th 2016


120) MET DNA Alterations in NSCLC--Reply (Clinical Cancer Research) Thursday July 14th 2016


121) MET DNA Alterations in NSCLC--Letter (Clinical Cancer Research) Thursday July 14th 2016


122) Holbrook Kohrt: In Memoriam (1977-2016) (Clinical Cancer Research) Thursday July 14th 2016


123) Measurable Pharmacodynamic Biomarkers of MET Activation (Clinical Cancer Research) Thursday July 14th 2016


124) ErbB2 Reactivates AR (Clinical Cancer Research) Thursday July 14th 2016


125) Double-Edged Sword of DDR2 (Clinical Cancer Research) Thursday July 14th 2016


126) Patterns of microRNA Expression through the Course of Disease (Clinical Cancer Research) Thursday July 14th 2016


127) Micrometastatic Disease in Ewing Sarcoma (Clinical Cancer Research) Thursday July 14th 2016


128) EMT and Inflammatory Tumor Microenvironment in Lung Cancer (Clinical Cancer Research) Thursday July 14th 2016


129) Large Cell Neuroendocrine Carcinoma Genomics (Clinical Cancer Research) Thursday July 14th 2016


130) Immunologic and Metabolic Features can Define PDA Prognosis (Clinical Cancer Research) Thursday July 14th 2016


131) MYC Mutations in DLBCL Have Variable Prognostic Impact (Clinical Cancer Research) Thursday July 14th 2016


132) Notch1 Regulates the Aggressiveness of DTC (Clinical Cancer Research) Thursday July 14th 2016


133) Selective PD-L1 Expression on CD44+ SCCHN Cells (Clinical Cancer Research) Thursday July 14th 2016


134) Low-Dose HDACi Treatment for Malignant Rhabdoid Tumor (Clinical Cancer Research) Thursday July 14th 2016


135) MDM2 Inhibition in Adenoid Cystic Carcinoma (Clinical Cancer Research) Thursday July 14th 2016


136) MiR-182 Targets RAD51 and HR in AML (Clinical Cancer Research) Thursday July 14th 2016


137) Inhibition of FOXM1-Mediated DNA Repair by Imipramine Blue (Clinical Cancer Research) Thursday July 14th 2016


138) Metabolomics of GBM (Clinical Cancer Research) Thursday July 14th 2016


139) TRAIL-Armed Exosomes as a Novel Antitumor Therapy (Clinical Cancer Research) Thursday July 14th 2016


140) GIV as a Recurrence Marker in Stage II Colon Cancer (Clinical Cancer Research) Thursday July 14th 2016


141) KIT Exon 11 Codons 557-558 Deletion Promotes GIST Liver Meta (Clinical Cancer Research) Thursday July 14th 2016


142) Haploidentical versus Matched Sibling for ALL in CR1 (Clinical Cancer Research) Thursday July 14th 2016


143) Niclosamide in Adrenal Cancer (Clinical Cancer Research) Thursday July 14th 2016


144) Elevated Anti-EBVgp350 Antibodies and Lower NPC Risk (Clinical Cancer Research) Thursday July 14th 2016


145) Improvement of Bispecific Antibody by Insertion of IL15 (Clinical Cancer Research) Thursday July 14th 2016


146) Clinical Uses of Multispectral Optoacoustic Tomography (Clinical Cancer Research) Thursday July 14th 2016


147) Cancer Immunotherapies against B7-H3 (Clinical Cancer Research) Thursday July 14th 2016


148) EMT and Tumor Immune Suppression (Clinical Cancer Research) Thursday July 14th 2016


149) Engineered Multivalent Therapeutics (Clinical Cancer Research) Thursday July 14th 2016


150) Metabolic Volume and Clinical Indices (Clinical Cancer Research) Friday July 1st 2016


151) Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL--Letter (Clinical Cancer Research) Friday July 1st 2016


152) Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL--Reply (Clinical Cancer Research) Friday July 1st 2016


153) Letter to the Editor (Clinical Cancer Research) Friday July 1st 2016


154) A PML-I/Thrombospondin-2 Axis Regulates Angiogenesis (Clinical Cancer Research) Friday July 1st 2016


155) Immunosuppressive Effect of Soluble BCMA in MM (Clinical Cancer Research) Friday July 1st 2016


156) The Role of SIRT6 in HCC (Clinical Cancer Research) Friday July 1st 2016


157) Epigenetic Signature for Lung Cancer Diagnosis (Clinical Cancer Research) Friday July 1st 2016


158) Mitochondria in Breast Cancer (Clinical Cancer Research) Friday July 1st 2016


159) Salivary Biomarkers for Oral Cancer Detection (Clinical Cancer Research) Friday July 1st 2016


160) IL-9 in CTCL (Clinical Cancer Research) Friday July 1st 2016


161) Role of Ebp1 in AML Cells (Clinical Cancer Research) Friday July 1st 2016


162) Androgen-Induced Radiosensitization in Prostate Cancer (Clinical Cancer Research) Friday July 1st 2016


163) Cancer-Initiating Cell Targeting Immunotherapy (Clinical Cancer Research) Friday July 1st 2016


164) CEA TCB antibody targeting solid tumors (Clinical Cancer Research) Friday July 1st 2016


165) EGFR Exon 19 Deletion False Negatives (Clinical Cancer Research) Friday July 1st 2016


166) Effects of Immune-Related eQTLs on Cutaneous Melanoma Prognosis (Clinical Cancer Research) Friday July 1st 2016


167) Sym004 Overcomes EGFR-Mediated Cetuximab Resistance (Clinical Cancer Research) Friday July 1st 2016


168) Change in Immune Signature Predicts Response to Trastuzumab (Clinical Cancer Research) Friday July 1st 2016


169) Therapeutic Vaccine for HPV-Infected Women (Clinical Cancer Research) Friday July 1st 2016


170) Phase I Study of Veliparib with Irinotecan (Clinical Cancer Research) Friday July 1st 2016


171) IL6 Polymorphism Predicts Bevacizumab Efficacy (Clinical Cancer Research) Friday July 1st 2016


172) Ixabepilone and Sunitinib in Advanced Solid Tumors (Clinical Cancer Research) Friday July 1st 2016


173) Micrometastasis Volume Determines Recurrence of Stage II CRC (Clinical Cancer Research) Friday July 1st 2016


174) Effect of Abituzumab on Bone Lesions in mCRPC (Clinical Cancer Research) Friday July 1st 2016


175) Adjuvant Immunotherapy in Pediatric Sarcomas (Clinical Cancer Research) Friday July 1st 2016


176) Phase II/III Naptumomab Estafenatox Plus IFN versus IFN in RCC (Clinical Cancer Research) Friday July 1st 2016


177) Tamoxifen Dose Escalation and Therapeutic Drug Monitoring (Clinical Cancer Research) Friday July 1st 2016


178) BIND-014 Nanoparticle in Solid Tumors (Clinical Cancer Research) Friday July 1st 2016


179) NF1-Mutant Lung Cancer (Clinical Cancer Research) Friday July 1st 2016


180) Preclinical Methods in Radiobiology (Clinical Cancer Research) Friday July 1st 2016


181) DNA Repair in Metastasis (Clinical Cancer Research) Friday July 1st 2016


182) Talimogene Laherparepvec in Melanoma (Clinical Cancer Research) Friday July 1st 2016


183) Testosterone in Androgen Receptor Signaling and DNA Repair (Clinical Cancer Research) Friday July 1st 2016


184) Individualized Tamoxifen Dose Escalation (Clinical Cancer Research) Friday July 1st 2016


185) Correction: Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients (Clinical Cancer Research) Wednesday June 15th 2016


186) NDUFA4L2 in HCC Development (Clinical Cancer Research) Wednesday June 15th 2016


187) Epigenetic Regulation of MSX1 in Ovarian Cancer (Clinical Cancer Research) Wednesday June 15th 2016


188) HMGB1 Isoforms in Asbestos Exposure and Mesothelioma (Clinical Cancer Research) Wednesday June 15th 2016


189) IgG Glycome in Colorectal Cancer (Clinical Cancer Research) Wednesday June 15th 2016


190) Strong Prognostic Value of Multiparametric ccfDNA Analysis (Clinical Cancer Research) Wednesday June 15th 2016


191) TIGIT Associates with T-Cell Exhaustion in AML (Clinical Cancer Research) Wednesday June 15th 2016


192) MET DNA Alterations in NSCLC (Clinical Cancer Research) Wednesday June 15th 2016


193) SMAD4 Loss Is Associated with Poor Survival in Colon Cancer (Clinical Cancer Research) Wednesday June 15th 2016


194) Neoadjuvant Chemotherapy and Tumor Immunity (Clinical Cancer Research) Wednesday June 15th 2016


195) CD74 in Stage III Melanoma (Clinical Cancer Research) Wednesday June 15th 2016


196) Plasma Cells, CD8 T Cells, and Survival in Ovarian Cancer (Clinical Cancer Research) Wednesday June 15th 2016


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()